{{Drugbox
| verifiedrevid = 462248547
| IUPAC_name = (''RS'')-''N''-(2,6-dimethylphenyl)- 1-methyl-piperidine-2-carboxamide
| image = Mepivacaine.png
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CDI|mepivacaine}}
| MedlinePlus = a603026
| pregnancy_category = C, use w/ caution, may cause fetal bradycardia
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
<!--Identifiers-->
| IUPHAR_ligand = 7224
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 96-88-8
| ATC_prefix = N01
| ATC_suffix = BB03
| ATC_supplemental =  
| PubChem = 4062
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00961
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3922
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = B6E06QE59J
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08181
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 6759
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1087
<!--Chemical data-->
| C=15 | H=22 | N=2 | O=1
| molecular_weight = 246.348 g/mol
| smiles = O=C(Nc1c(cccc1C)C)C2N(C)CCCC2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = INWLQCZOYSRPNW-UHFFFAOYSA-N
}}

'''Mepivacaine''' {{IPAc-en|m|ɛ|ˈ|p|ɪ|v|ə|k|eɪ|n}} is a [[local anesthetic]]<ref name="pmid17195831">{{cite journal |vauthors=Porto GG, Vasconcelos BC, Gomes AC, Albert D |title=Evaluation of lidocaine and mepivacaine for inferior third molar surgery |journal=Med Oral Patol Oral Cir Bucal |volume=12 |issue=1 |pages=E60–4 |date=January 2007 |pmid=17195831 |doi= |url=http://www.medicinaoral.com/medoralfree01/v12i1/medoralv12i1p60.pdf}}</ref> of the amide type.  Mepivacaine has a reasonably rapid onset (more rapid than that of [[procaine]]) and medium duration of action (shorter than that of procaine) and is marketed under various [[trade name]]s including '''Carbocaine''' and '''Polocaine'''.

Mepivacaine became available in the [[United States]] in the 1960s.

Mepivacaine is used in any infiltration and [[regional anesthesia]].

It is supplied as the hydrochloride salt of the [[racemate]], <ref name="pmid8989005">{{cite journal |vauthors=Burm AG, Cohen IM, van Kleef JW, Vletter AA, Olieman W, Groen K |title=Pharmacokinetics of the enantiomers of mepivacaine after intravenous administration of the racemate in volunteers |journal=Anesth. Analg. |volume=84 |issue=1 |pages=85–9 |date=January 1997 |pmid=8989005 |doi= 10.1097/00000539-199701000-00016|url=http://www.anesthesia-analgesia.org/cgi/pmidlookup?view=long&pmid=8989005}}</ref> which consists of R(-)-mepivacaine and S(+)-mepivacaine in equal proportions.   These two enantiomers have markedly different pharmacokinetic properties.  <ref> http://journals.lww.com/anesthesia-analgesia/Fulltext/1997/01000/Pharmacokinetics_of_the_Enantiomers_of_Mepivacaine.16.aspx </ref>

==References==
{{Reflist}}

==External links==
*[http://www.rxlist.com/cgi/generic2/mepivacaine.htm Mepivacaine at RxList]

{{Local anesthetics}}

[[Category:Local anesthetics]]
[[Category:Piperidines]]
[[Category:Anilides]]


{{nervous-system-drug-stub}}